These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33311014)

  • 21. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease.
    Koivuviita N; Tertti R; Järvisalo M; Pietilä M; Hannukainen J; Sundell J; Nuutila P; Knuuti J; Metsärinne K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2773-9. PubMed ID: 19369689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of vascular function in patients with chronic kidney disease.
    Jablonski KL; Decker E; Perrenoud L; Kendrick J; Chonchol M; Seals DR; Jalal D
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24962357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
    Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
    Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Vascular Endothelium in Chronic Kidney Disease: A Novel Target for Aerobic Exercise.
    Martens CR; Kirkman DL; Edwards DG
    Exerc Sport Sci Rev; 2016 Jan; 44(1):12-9. PubMed ID: 26509484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation.
    Lekakis J; Abraham P; Balbarini A; Blann A; Boulanger CM; Cockcroft J; Cosentino F; Deanfield J; Gallino A; Ikonomidis I; Kremastinos D; Landmesser U; Protogerou A; Stefanadis C; Tousoulis D; Vassalli G; Vink H; Werner N; Wilkinson I; Vlachopoulos C
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):775-89. PubMed ID: 21450600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of systemic microvascular endothelial and smooth muscle function in individuals with early-onset coronary artery disease: studies with laser speckle contrast imaging.
    Souza EG; De Lorenzo A; Huguenin G; Oliveira GM; Tibiriçá E
    Coron Artery Dis; 2014 Jan; 25(1):23-8. PubMed ID: 24172594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of peripheral microvascular dysfunction and erectile dysfunction.
    Gerber RE; Vita JA; Ganz P; Wager CG; Araujo AB; Rosen RC; Kupelian V
    J Urol; 2015 Feb; 193(2):612-7. PubMed ID: 25196657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative stress and endothelial dysfunction in chronic kidney disease.
    Costa-Hong V; Bortolotto LA; Jorgetti V; Consolim-Colombo F; Krieger EM; Lima JJ
    Arq Bras Cardiol; 2009 May; 92(5):381-6, 398-403, 413-8. PubMed ID: 19629295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Microvascular and Endothelial Dysfunction in the Nonculprit Territory in Patients With Acute Myocardial Infarction.
    Díez-Delhoyo F; Gutiérrez-Ibañes E; Sanz-Ruiz R; Vázquez-Álvarez ME; González Saldívar H; Rivera Juárez A; Sarnago F; Martínez-Sellés M; Bermejo J; Soriano J; Elízaga J; Fernández-Avilés F
    Circ Cardiovasc Interv; 2019 Feb; 12(2):e007257. PubMed ID: 30722689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
    Bartnicki P; Kowalczyk M; Franczyk-Skóra B; Baj Z; Rysz J
    Curr Vasc Pharmacol; 2016; 14(4):360-7. PubMed ID: 26759218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between IL-10 levels and cardiovascular events in patients with CKD.
    Yilmaz MI; Solak Y; Saglam M; Cayci T; Acikel C; Unal HU; Eyileten T; Oguz Y; Sari S; Carrero JJ; Stenvinkel P; Covic A; Kanbay M
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1207-16. PubMed ID: 24789549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endothelial function: role, assessment and limits].
    Puissant C; Abraham P; Durand S; Humeau-Heurtier A; Faure S; Rousseau P; Mahé G
    J Mal Vasc; 2014 Feb; 39(1):47-56. PubMed ID: 24355615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Damage of the endothelial glycocalyx in chronic kidney disease.
    Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P
    Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to evaluate microvascular organ damage in hypertension: assessment of endothelial function.
    Virdis A; Taddei S
    High Blood Press Cardiovasc Prev; 2011 Dec; 18(4):163-7. PubMed ID: 22283670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypovitaminosis D is associated with endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang QY; Jiang CM; Sun C; Tang TF; Jin B; Cao DW; He JS; Zhang M
    J Nephrol; 2015 Aug; 28(4):471-6. PubMed ID: 25515034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.
    Charytan DM; Padera R; Helfand AM; Zeisberg M; Xu X; Liu X; Himmelfarb J; Cinelli A; Kalluri R; Zeisberg EM
    Int J Cardiol; 2014 Sep; 176(1):99-109. PubMed ID: 25049013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Most exposed: the endothelium in chronic kidney disease.
    Vila Cuenca M; Hordijk PL; Vervloet MG
    Nephrol Dial Transplant; 2020 Sep; 35(9):1478-1487. PubMed ID: 31071222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.